Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

VHTvsRSPHETF Comparison

ETF 1
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
+0.32%
VS
ETF 2
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of
US Health Care
+0.32%

Vanguard Health Care ETF (VHT) and Invesco S&P 500® Equal Weight Health Care ETF (RSPH) belong to the same industry segment: US Health Care. VHT's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, RSPH's top sector exposures are Healthcare, Consumer Non-Cyclicals  VHT is less expensive with a Total Expense Ratio (TER) of 0.09%, versus 0.4% for RSPH. VHT is up 6.79% year-to-date (YTD) with -$84M in YTD flows. RSPH performs worse with 6.5% YTD performance, and -$43M in YTD flows. Run a side-by-side ETF comparison of VHT and RSPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

VHT vs RSPH performance and flow charts

Performance

0.02.04.06.08.0%Jun 24Jul 1Jul 9Jul 16Jul 23

Cumulative Flows

0 M50 M100 M150 MJun 24Jul 1Jul 9Jul 16Jul 23

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/24/2026
1M3MYTD1Y3Y5Y
Perf.
VHT
RSPH
+5.71%+4.64%
+13.44%+10.83%
+6.79%+6.50%
+24.07%+16.76%
+27.86%+13.38%
+29.60%+15.56%
Flows
VHT
RSPH
+$148M+$51M
+$135M-$20M
-$84M-$43M
-$322M-$71M
-$2.43B-$347M
-$679M-$228M
Volatility and drawdown
3M1Y3Y5Y
Volatility
VHT
RSPH
+17.46%+17.31%
+15.29%+16.07%
+14.31%+15.30%
+15.40%+16.50%
Max drawdown
VHT
RSPH
-3.84%-3.58%
-10.39%-10.87%
-16.88%-16.96%
-17.77%-21.91%
Max drawdown duration
VHT
RSPH
17d17d
169d116d
435d434d
767d817d
Trading data

Create an account to view trading data

Join for free
VHT
RSPH
Last sale
7/27/2026 at 3:47 PM
$307.75
$34.26
Previous close
07/24/2026
$305.07
$33.80
Consolidated volume
07/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
VHT
RSPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/27/2026 at 3:47 PM
Live
Closed
VHT
RSPH
Last price
$307.75
$34.26
1D performance
+0.88%
+1.35%
AuM$18.27 B$744.71 M
E/R0.09%0.4%
Characteristics
VHT
RSPH
Management strategyPassivePassive
ProviderVanguardInvesco
BenchmarkMSCI US IMI Health Care 25/50 IndexS&P 500 Equal Weight Health Care Index
N° of holdings41959
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2004November 1, 2006
ESGNoNo
Advertisement
Exposure

Countries

VHT
USA
96.86%
Other
3.14%
RSPH
USA
96.71%
Other
3.29%

Sectors

VHT
Healthcare
97.39%
Other
2.61%
RSPH
Healthcare
98.29%
Other
1.71%
Advertisement

Diversification

VHT

Total weight of top 15 holdings out of 15

61.42%
RSPH

Total weight of top 15 holdings out of 15

27.58%

Top 15 holdings

Data as of June 30, 2026
VHT
Eli Lilly & Co.
14.16%
Johnson & Johnson
8.87%
AbbVie, Inc.
6.54%
UnitedHealth Group, Inc.
5.55%
Merck & Co., Inc.
4.67%
Amgen, Inc.
2.87%
Thermo Fisher Scientific, Inc.
2.74%
Abbott Laboratories
2.32%
Gilead Sciences, Inc.
2.31%
Intuitive Surgical, Inc.
2.08%
Pfizer Inc.
2.01%
CVS Health Corp.
1.93%
Vertex Pharmaceuticals, Inc.
1.86%
Danaher Corp.
1.78%
Bristol Myers Squibb Co.
1.73%
RSPH
Moderna, Inc.
2.35%
Bio-Techne Corp.
2.17%
Charles River Laboratories International, Inc.
1.86%
Vertex Pharmaceuticals, Inc.
1.81%
AbbVie, Inc.
1.81%
Mettler-Toledo International, Inc.
1.79%
Revvity, Inc.
1.79%
Biogen, Inc.
1.79%
Cardinal Health, Inc.
1.77%
DaVita, Inc.
1.76%
Baxter International, Inc.
1.74%
Merck & Co., Inc.
1.74%
Incyte Corp.
1.73%
Henry Schein, Inc.
1.73%
Stryker Corp.
1.73%
Frequently asked questions about VHT and RSPH

How have the VHT and RSPH ETFs performed in 2026?

As of July 24, 2026, VHT is up 6.79% year-to-date (YTD), while RSPH has returned 6.5%. That puts VHT better performer ahead so far this year.

Which ETF is attracting more investor money: VHT or RSPH?

Year-to-date, the VHT ETF saw -$84M in flows, compared to -$43M for RSPH.

Which ETF is more volatile: VHT or RSPH?

Over the past year, VHT had a volatility of 15.29%, while RSPH experienced 16.07%.

Which ETF is bigger: VHT or RSPH?

As of July 24, 2026, VHT holds $18.27 B in assets under management (AUM), while RSPH manages $744.71 M.

What sectors do the VHT and RSPH ETFs invest in?

VHT leans toward sectors like Healthcare. Meanwhile, RSPH focuses on Healthcare.

What are the top holdings of the VHT ETF and RSPH ETF?

VHT top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. RSPH holds in its top three: Moderna, Inc., Bio-Techne Corp. and Charles River Laboratories International, Inc..

Which ETF is more diversified: VHT or RSPH?

VHT holds 419 securities with 61.42% of its assets in the top 15. RSPH has 59 securities and a top 15 weight of 27.58%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder